Cents and Sensibility - Kimberly and Friends' Consortium Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: StoxRider who wrote (61645)	1/12/2000 6:38:00 PM
From: $Mogul	Read Replies (5) of 108040

ISIP- Yeah the current price is a joke. That Re-iteration should make shorts very scared. $40-$50 and the stock is at $10... and has immense volume..yeah I would think there will be a short squeeze in the coming days. Princeton, New Jersey, Jan. 7 (Bloomberg Data) -- Isis Pharmaceuticals Inc. (ISIP US) was reiterated short-term ``outperform' by analyst Jeffrey J. Kraws at Gruntal & Co. The long-term rating was also reiterated 'outperform.' The short-term and long-term price targets are $43 and $52 per share, respectively.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next